Anal canal cancer is one of the few cancers usually cured without major surgery. The primary treatment is organ-preserving chemoradiation — most patients keep their sphincter and avoid a permanent colostomy. Dr. Vinod T. Gore coordinates this multidisciplinary care and performs salvage and reconstructive surgery when it is needed.
The anal canal is the short final passage of the bowel — about 3–4 cm long — that ends at the anal opening. Although it sits right next to the rectum, anal cancer is a different disease. Most anal cancers are squamous cell carcinomas, the same cell type as skin and cervix — not the glandular type seen in colon and rectal cancer.
This difference matters enormously, because it changes the treatment. Unlike colon or rectal cancer — where surgery comes first — anal cancer responds beautifully to a combination of chemotherapy and radiotherapy. This organ-preserving approach cures most patients while keeping the sphincter intact, so a permanent colostomy is usually avoided.
The great majority of anal cancers are linked to the human papillomavirus (HPV) — the same virus behind cervical cancer — which means much of it is preventable through HPV vaccination and screening of high-risk groups.
Anal cancer is strongly linked to long-standing HPV infection. The risk factors below are discussed openly and without judgement — understanding them helps with prevention and early detection.
Prevention matters. Because most anal cancers are HPV-related, the HPV vaccine substantially lowers the risk, and stopping smoking helps further. High-risk individuals may benefit from surveillance to catch pre-cancerous changes early.
Anal cancer is very often mistaken for piles (haemorrhoids) or a fissure — which is why persistent symptoms must always be examined properly.
Staging is based mainly on the size of the tumour and whether lymph nodes are involved. Assessment includes examination under anaesthesia, biopsy, pelvic MRI, CT or PET-CT, and an HIV test where appropriate.
| Stage | Classification | Description | 5-yr Survival |
|---|---|---|---|
Stage I | T1 (≤2 cm), N0 | Small tumour confined to the anus. Chemoradiation is highly curative; tiny margin tumours may be locally excised. | 80–90% |
Stage II | T2–T3 (>2 cm), N0 | Larger tumour, no nodes. Treated with chemoradiation, preserving the sphincter. | 70–80% |
Stage III | Node-positive or T4 | Spread to nearby or groin lymph nodes, or invading nearby organs. Chemoradiation; salvage surgery if residual disease. | 50–65% |
Stage IV | Any T, Any N, M1 | Spread to distant organs. Systemic chemotherapy, with radiotherapy or surgery for selected situations. | Variable |
For anal cancer the order is different from colon and rectal cancer — treatment is led by chemoradiation, not surgery.
The aim in anal cancer is to cure the disease while keeping the anus and sphincter working — so most patients never need a permanent bag. That is achieved with chemoradiation as the primary treatment, with surgery held in reserve.
The cornerstone of anal cancer treatment is combined chemoradiation — chemotherapy (5-fluorouracil and mitomycin) given alongside radiotherapy, the approach pioneered by Dr. Norman Nigro. Delivered over about 5–6 weeks, it cures the great majority of patients while keeping the anus and sphincter intact, so a permanent colostomy is avoided. Dr. Gore, as surgical oncologist, leads the multidisciplinary team that plans and coordinates this care, monitors the response, and steps in surgically only if it is needed.
Dr. Gore performs the surgical procedures for anal cancer when chemoradiation does not fully clear the disease, or for selected early tumours.
Yes — for most patients. The main curative treatment is chemoradiation (chemotherapy with radiotherapy), which cures the majority while keeping the anus and sphincter intact. Surgery is only needed if the cancer does not fully clear or comes back.
Usually not. Because anal cancer is treated mainly with chemoradiation rather than surgery, most patients keep their sphincter and never need a bag. A permanent colostomy is only required if salvage surgery (APR) becomes necessary.
No. Although the anus sits right next to the rectum, anal cancer is usually a squamous cell carcinoma (like skin or cervix), whereas colon and rectal cancers are glandular. This is why anal cancer is treated with chemoradiation first, not surgery first.
Most anal cancers are linked to the human papillomavirus (HPV) — the same virus that causes cervical cancer. The HPV vaccine substantially reduces the risk, and stopping smoking lowers it further.
You can’t tell from symptoms alone, which is exactly why persistent anal bleeding, a lump or ongoing pain should always be examined and, if needed, biopsied. Many anal cancers are first mistaken for haemorrhoids.
Salvage surgery is an operation — usually abdominoperineal resection (APR) — offered when anal cancer remains or returns after chemoradiation. It removes the affected area completely and offers a further chance of cure.
Bring your biopsy report, MRI and any scans. Dr. Gore will review everything personally, coordinate your multidisciplinary care, and explain how organ preservation applies to you.